Imclone systems (IMCL) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Imclone systems (IMCL)

IMCL 0.159

0.0%

Oct 5 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: QuietWon who wrote (385)	3/11/1999 9:34:00 AM
From: CPAMarty	Read Replies (1) of 2515

CEO said that C225 could be on the market in 18 mos. Very positive interview!!!!!!!! CEO answered question on risk of Phase III very effectively; C225 has demonstrated positive results in combination with radiation in about 200 cases. In in 60% of cases where chemo is failing and C225 was used there was a major response including elimination of the tumor all together. CEO said that he is confident the the drug has efficacy

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next